Found: 15
Select item for more details and to access through your institution.
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03269-3
- By:
- Publication type:
- Article
The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9249, doi. 10.3390/ijms21239249
- By:
- Publication type:
- Article
Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221142924
- By:
- Publication type:
- Article
Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, v. 15, p. 1, doi. 10.1177/17562864221142924
- By:
- Publication type:
- Article
Dalfampridine effects on cognition, fatigue, and dexterity.
- Published in:
- Brain & Behavior, 2017, v. 7, n. 1, p. n/a, doi. 10.1002/brb3.559
- By:
- Publication type:
- Article
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129182
- By:
- Publication type:
- Article
Aggressive spinal cord involvement in granulomatosis with polyangiitis.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod—potentials and risks of subsequent highly active agents.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 5, p. 2806, doi. 10.1007/s00415-021-10956-1
- By:
- Publication type:
- Article
Sirolimus leads to rapid and sustained clinical improvement of motor deficits in a patient with inclusion body myositis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 4, p. 1284, doi. 10.1111/ene.15231
- By:
- Publication type:
- Article
Status of clinical research in neurology in Germany—A national survey.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1446, doi. 10.1111/ene.14763
- By:
- Publication type:
- Article
Pain, depression, and quality of life in adults with MOG‐antibody–associated disease.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1645, doi. 10.1111/ene.14729
- By:
- Publication type:
- Article
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00219-3
- By:
- Publication type:
- Article
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00219-3
- By:
- Publication type:
- Article
Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 9, p. 1243, doi. 10.3390/cells12091243
- By:
- Publication type:
- Article
The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 787, doi. 10.3390/ijms25020787
- By:
- Publication type:
- Article